July 11, 2026 03:36 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Foreign franchise league enters India! BBL opener to be played in Chennai, announce Modi-Albanese | 'They could have stopped me': Vijay blames police, former DMK government over Karur stampede | 'People will correct their 2025 mistake': Electoral debutant Prashant Kishor predicts BJP defeat in Bankipur | New assassination plot against Trump? Israel's secret intelligence raises alarm amid escalating Middle East tension | Ayatollah Ali Khamenei buried at Iran's holiest shrine as Middle East crisis deepens | Indian techie allegedly kills wife in US, sends photo of her body to 'secret girlfriend' in India; arrested | 'I fled the city': Thane doctor quits after alleged assault by Shiv Sena leader | Sensex surges 500 points before losing steam, ends marginally higher after volatile trading session | US court drops charges against Indian-origin doctor who drove Tesla off 250-foot cliff with family | Dalal Street bleeds! Sensex tanks over 1,600 points after Trump declares Iran ceasefire 'over'

Humble vitamin C tablet key to Deakin diabetes breakthrough

| @indiablooms | Feb 25, 2019, at 05:17 pm

New York, Feb 25 (IBNS): A new study from Deakin University has found that taking 500mg of vitamin C twice daily can help those with type 2 diabetes by lowering elevated blood sugar levels across the day and minimising spikes in blood sugar after meals.

The randomised cross-over study, recently published in the journal Diabetes, Obesity and Metabolism, also found vitamin C lowered blood pressure in people with type 2 diabetes, suggesting benefits for heart health too.

Lead researcher Associate Professor Glenn Wadley, from Deakin's Institute for Physical Activity and Nutrition, said the results may help the 1.2 million Australians currently living with type 2 diabetes.

"We found that participants had a significant 36 per cent drop in the blood sugar spike after meals. This also meant that they spent almost three hours less per day living in a state of hyperglycaemia," Associate Professor Wadley said.

"This is extremely positive news as hyperglycaemia is a risk factor for cardiovascular disease in people living with type 2 diabetes.

"We also found that the proportion of people with hypertension halved after taking the vitamin C capsules, with both their systolic and diastolic blood pressure levels dropping significantly."

Associate Professor Wadley said the dose of vitamin C used in the study was about 10 times the normal dietary intake and readily available from most health food stores.

"Vitamin C's antioxidant properties can help counteract the high levels of free radicals found in people with diabetes, and it's encouraging to see this benefits a number of the disease's common comorbidities, such as high blood pressure," he said.

Associate Professor Wadley said diabetes was a fast growing problem in Australia, with more than 100,000 Australians developing diabetes in the past year.

"While physical activity, good nutrition and current diabetes medications are standard care and very important for managing type 2 diabetes, some people can find it tough to manage their blood glucose levels even with medication," he said.

"We need to find new ways to help people with type 2 diabetes reduce the incidence and severity of diabetic complications and improve their quality of life.

"For people living with type 2 diabetes, vitamin C could be a potentially cheap, convenient and effective additional therapy, used in addition to their usual anti-diabetic treatments to improve glycaemic control."

This study was funded by a grant awarded by the Diabetes Australia Research Trust.

Previous research by Associate Professor Wadley found that vitamin C works to counteract free radicals and improve the disposal of blood glucose in people with type 2 diabetes. This is due to vitamin C's known antioxidant properties, which improve the capacity of the muscle to remove the by-products of energy expenditure that interfere with insulin's actions.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.